Evidence map›Paper›PMID 42403806›Full record

ArticleCureus2026

Atrial Flutter-Triggered Ventricular Tachycardia Storm in Gitelman Syndrome: A Case Report.

Mohamed Elganainy, Ahmed Sami Hammami, Joshua Peltz, Osejie Fidelis Oriaifo

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed ElganainyInternal Medicine, ECU Health, Greenville, USA.
Ahmed Sami HammamiCardiovascular Medicine, ECU Health, Greenville, USA.
Joshua PeltzCardiovascular Medicine, ECU Health, Greenville, USA.
Osejie Fidelis OriaifoCardiovascular Medicine, ECU Health, Greenville, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gitelman syndrome is an inherited renal tubulopathy characterized by hypokalemia and hypomagnesemia, which can increase susceptibility to cardiac arrhythmias. Although ventricular arrhythmias have been reported, ventricular tachycardia (VT) storm triggered by atrial tachyarrhythmia with recurrent implantable cardioverter-defibrillator (ICD) therapies is uncommon. A 68-year-old woman with Gitelman syndrome, chronic kidney disease stage IIIa, long-QT physiology, and sinus bradycardia status post pacemaker implantation with subsequent dual-chamber ICD placement presented after palpitations followed by over 35-40 ICD therapies. Initial laboratory evaluation showed profound hypokalemia (2.2 mmol/L) and hypomagnesemia (1.6 mg/dL). Electrocardiography demonstrated a narrow-complex atrial tachyarrhythmia most consistent with atrial flutter, while device interrogation revealed a rapid atrial tachyarrhythmia preceding ventricular tachyarrhythmic events. The episode was clinically interpreted as atrial flutter degenerating into sustained VT. After intravenous potassium, magnesium, and metoprolol, she converted to an atrial-paced rhythm but subsequently developed transient rebound hyperkalemia necessitating temporizing therapy. Echocardiography showed preserved left ventricular systolic function. This report highlights a trigger-mediated VT storm in the absence of structural left ventricular dysfunction. Key management strategies included strict electrolyte control, avoidance of proarrhythmic triggers, optimization of ICD programming, and consideration of an electrophysiology study with potential ablation.

Indexed as

anti tachycardia pacinggitelman syndromehypokalemiaicd stormventricular tachycardia (vt) storm

Identifiers

PMID42403806
PMCPMC13327843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.